Late Infantile-Onset Globoid Cell Leukodystrophy: Treatment using Hematopoietic Stem Cell Transplantation
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Globoid cell leukodystrophy is a rare autosomal recessive disorder of the brain white-matter caused by galactosylceramidase deficiency; the disorder is classified into four types based on the age of onset. Approximately 80-85% of patients have an early infantile form, while 10-15% has a late infantile form. Globoid cell leukodystrophy leads to a progressive neurological deterioration, and affected patients rarely survive more than 2-3 years. Although many different treatments have been investigated over several decades, further research is still needed. Hematopoietic stem cell transplantation is the standard treatment for globoid cell leukodystrophy. Here, we report a case of symptomatic late-infantile globoid cell leukodystrophy treated with stem cell transplantation. After transplantation, disease progression ceased and cognitive and motor function improved. And a 6 months follow-up study using brain magnetic resonance imaging showed white matter involvement was increased. After that, annual follow-up brain magnetic resonance imaging showed a stable status of disease.
Abstract
Globoid cell leukodystrophy is a rare autosomal recessive disorder of the brain white-matter caused by galactosylceramidase deficiency; the disorder is classified into four types based on the age of onset. Approximately 80-85% of patients have an early infantile form, while 10-15% has a late infantile form. Globoid cell leukodystrophy leads to a progressive neurological deterioration, and affected patients rarely survive more than 2-3 years. Although many different treatments have been investigated over several decades, further research is still needed. Hematopoietic stem cell transplantation is the standard treatment for globoid cell leukodystrophy. Here, we report a case of symptomatic late-infantile globoid cell leukodystrophy treated with stem cell transplantation. After transplantation, disease progression ceased and cognitive and motor function improved. And a 6 months follow-up study using brain magnetic resonance imaging showed white matter involvement was increased. After that, annual follow-up brain magnetic resonance imaging showed a stable status of disease.
참고문헌 (18)
- Suzuki K, "Globoid cell leukodystrophy (Krabbe's disease): update", J Child Neurol, 18, pp.595~603 (2003)[DOI]
- Spiegel R, "A mutation in the saposin A coding region of the prosaposin gene in an infant presenting as Krabbe disease: first report of saposin A deficiency in humans", Mol Genet Metab, 84, pp.160~166 (2005)[DOI]
- Suzuki K, "Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase", Proc Natl Acad Sci U S A, 66, pp.302~309 (1970)[DOI]
- Wenger DA, "Krabbe disease: genetic aspects and progress toward therapy", Mol Genet Metab, 70, pp.1~9 (2000)[DOI]
- Krivit W, "Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy", N Engl J Med, 338, pp.1119~1126 (1998)[DOI]
- Escolar ML, "Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease", N Engl J Med, 352, pp.2069~2081 (2005)[DOI]
- Mikulka CR, "Treatment for Krabbe's disease: Finding the combination", J Neurosci Res, 94, pp.1126~1137 (2016)[DOI]
- Loes DJ, "Globoid cell leukodystrophy: distinguishing early-onset from late-onset disease using a brain MR imaging scoring method", AJNR Am J Neuroradiol, 20, pp.316~323 (1999)
- Furuya H, "Adult onset globoid cell leukodystrophy (Krabbe disease): analysis of galactosylceramidase cDNA from four Japanese patients", Hum Genet, 100, pp.450~456 (1997)[DOI]
- Tappino B, "Identification and characterization of 15 novel GALC gene mutations causing Krabbe disease", Hum Mutat, 31, pp.E1894~E1914 (2010)[DOI]
- Escolar ML, "A staging system for infantile Krabbe disease to predict outcome after unrelated umbilical cord blood transplantation", Pediatrics, 118, pp.e879~e889 (2006)[DOI]
- Svennerholm L, "Krabbe disease: a galactosylsphingosine (psychosine) lipidosis", J Lipid Res, 21, pp.53~64 (1980)
- Duffner PK, "Later onset phenotypes of Krabbe disease: results of the world-wide registry", Pediatr Neurol, 46, pp.298~306 (2012)[DOI]
- Gelinas J, "Child Neurology: Krabbe disease: a potentially treatable white matter disorder", Neurology, 79, pp.e170~e172 (2012)[DOI]
- Duffner PK, "Newborn screening for Krabbe disease: the New York State model", Pediatr Neurol, 40, pp.245~252 (2009)[DOI]
- Orchard PJ, "Transplant outcomes in leukodystrophies", Semin Hematol, 47, pp.70~78 (2010)[DOI]
- Lim ZY, "Sustained neurological improvement following reducedintensity conditioning allogeneic haematopoietic stem cell transplantation for late-onset Krabbe disease", Bone Marrow Transplant, 41, pp.831~832 (2008)[DOI]
- Duffner PK, "Early infantile Krabbe disease: results of the World-Wide Krabbe Registry", Pediatr Neurol, 45, pp.141~148 (2011)[DOI]